Standard Biotools Inc share price logo

Standard Biotools Inc Share Price

NASDAQ: LAB

Small Cap

$0.99

+0.03

(+2.69%)

as on

Standard Biotools Inc Stock Performance

as on March 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $0.95
    $1.00
    downward going graph

    4.04%

    Downside

    1.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.92
    $1.72
    downward going graph

    7.07%

    Downside

    73.74%

    Upside

    downward going graph

Standard Biotools Inc share price movements today

Previous Close
$0.96
Open
$0.95
Volume
1.9M
Day's Low - High
$0.95 - $1.00
52 Week Low - High
$0.92 - $1.72

Standard Biotools Inc Historical Returns

1 Month Return
-15.04 %
3 Month Return
-41.1 %
1 Year Return
-17.24 %
3 Year Return
-52.71 %
5 Year Return
0 %

Standard Biotools Inc Stock Fundamentals & Key Indicators

Check Standard Biotools Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$371.1M

EPS (TTM)

-0.05

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.69

Industry PE ratio

-4.340170068027211

PEG Ratio

0

EBITDA

-82.3M

Revenue (TTM)

85.3M

Profit Margin

-87.77%

Return On Equity TTM

-13.13%

Standard Biotools Inc Stock Valuation

Track how Standard Biotools Inc P/E has moved over time to understand its valuation trends.

Standard Biotools Inc in the last 5 years

  • Overview

  • Trends

Lowest (-13.82x)

December 31, 2025

Today (-4.69x)

March 20, 2026

Industry (-4.34x)

March 20, 2026

Highest (-0.50x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -4.69x

Standard Biotools Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Standard Biotools Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$371.1MNA-4.69-87.77%
BUY$105.8B83.1%36.7414.44%
BUY$132.3B47.72%41.1712.92%
BUY$188.5B-10.86%29.1614.72%
BUY$112.0B-25.51%24.3613.00%

Stock Returns calculator for Standard Biotools Inc Stock including INR - Dollar returns

The Standard Biotools Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Standard Biotools Inc investment value today

Current value as on today

₹93,891

Returns

₹6,109

(-6.11%)

Returns from Standard Biotools Inc Stock

₹14,655 (-14.66%)

Dollar Returns*

₹8,546 (+8.55%)

Analyst Recommendation on Standard Biotools Inc Stock

Based on 6 analysts

BUY

83.33%

Buy

16.67%

Hold

0.00%

Sell

Based on 6 analysts, 83.33% of analysts recommend a 'BUY' rating for Standard Biotools Inc. Average target price of $1.55

Standard Biotools Inc Share Price Target

Get share price movements and forecasts by analysts on Standard Biotools Inc.

What analysts predicted

36.13%UPSIDE

Target Price

$1.55

Current Price

$0.99

Analyzed by

6 Analysts

Target

$1.55

Standard Biotools Inc target price $1.55, a slight upside of 36.13% compared to current price of $0.99. According to 6 analysts rating.

Standard Biotools Inc Stock’s Investor Sentiment and Interest

Search interest for Standard Biotools Inc Stock has increased by 28% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:28% versus previous 30 day period

Standard Biotools Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
25
28
45
22
44
46
40
21
19
3
Gross Profit
11
13
24
10
23
21
19
10
9
2
Operating Income
-21
-21
-60
-30
-31
-32
-32
-25
-23
-11
EBITDA
-13
-14
-25
-20
-20
-26
-22
-14
-31
-18
Interest Expense
1
1
1
0
-
3
0
0
0
0
Depreciation
3
3
5
3
3
3
4
3
1
-
Income Before Tax
-20
-19
-32
-25
-26
-33
-26
-18
-32
-19
Income Tax Expense
0
0
0
0
0
0
0
0
-1
-35
Net Income
-20
-19
-32
-45
-26
-34
-26
-33
-34
19
Net Profit Margin
-82.77%
-70.16%
-70.61%
-203.26%
-59.90%
-72.93%
-63.81%
-153.75%
-177.41%
598.48%

Standard Biotools Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
104
101
112
117
138
130
97
106
174
85
Gross Profit
58
51
61
64
83
77
37
50
84
42
Operating Income
-73
-58
-48
-51
-51
-67
-116
-76
-175
-93
EBITDA
-56
-39
-31
-46
-34
-44
-173
-54
-118
-94
Interest Expense
5
5
13
4
3
3
4
4
3
0
Depreciation
-
-
16
15
15
15
15
14
16
-
Income Before Tax
-80
-63
-61
-66
-54
-63
-192
-74
-138
-96
Income Tax Expense
-4
-3
-2
-1
-1
-4
-2
0
0
-37
Net Income
-75
-60
-59
-64
-53
-59
-190
-74
-138
-74
Net Profit Margin
-72.75%
-59.38%
-52.24%
-55.26%
-38.38%
-45.36%
-194.08%
-70.21%
-79.62%
-87.77%

Standard Biotools Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-19
-32
-45
-26
-34
-26
-33
-34
19
Operating Cash Flow
-14
-62
-39
-27
-14
-30
-20
-22
-1
Investing Cash Flow
-13
318
50
-30
25
14
27
-6
-10
Financing Cash Flow
-1
-19
-28
0
-54
0
0
0
0
Change in Cash
-27
235
-17
-59
-43
-15
7
-29
-11

Standard Biotools Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-60
-59
-64
-53
-59
-190
-74
-138
-74
Operating Cash Flow
-24
-25
-35
-15
-44
-89
-43
-143
-74
Investing Cash Flow
17
4
-39
39
-11
-88
20
363
24
Financing Cash Flow
28
57
2
20
15
230
-6
-102
0
Change in Cash
23
37
-71
45
-40
52
-29
116
-48

Insights on Standard Biotools Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -34.68M → 19.28M (in $), with an average increase of 279.9% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Boston Scientific Corp. has given 1.7% return, outperforming this stock by 54.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Edwards Lifesciences Corp. has given 16.2% return, outperforming this stock by 33.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 5 quarters, 46.71M → 3.22M (in $), with an average decrease of 38.3% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, LAB stock has moved down by -41.1%

About Standard Biotools Inc

fluidigm (nasdaq:fldm) develops, manufactures and markets microfluidic systems for growth markets in the life sciences and in applied markets. fluidigm’s systems consist of instruments, software, integrated fluidic circuits (ifcs), high-performance assays for gene expression and genotyping, and primers for sample preparation for next-generation sequencing. fluidigm technology enables customers to perform thousands of sophisticated biochemical measurements in parallel on samples smaller than the content of a single cell, with nanoliter volumes of reagents, in half the area of a credit card. the company’s integrated customer solutions are designed to significantly simplify experimental workflows, increase throughput and reduce costs while delivering excellent data quality. based in south san francisco, fluidigm offers an exciting and collegial working environment with excellent compensation and benefits, including equity.
OrganisationStandard Biotools Inc
Headquarters50 Milk Street, Boston, MA, United States, 02109
IndustryTechnology
CEODr. Michael Egholm Ph.D.
E-voting on sharesClick here to vote

Key Management of Standard Biotools Inc

Name

Title

Mr. Jonathan Mickelsen

VP & Chief Accounting Officer

John Graziano

Vice President of Investor Relations

Ms. Elizabeth R. Jensen

Chief Human Resources Officer

Mr. Mike Musgnug

Senior VP & Chief Commercial Officer

Dr. Michael Egholm Ph.D.

President, CEO & Director

Mr. Hanjoon Kim

Chief Financial Officer

Mr. Sean Mackay

Chief Business Officer & Senior VP

FAQs

What is Standard Biotools Inc share price today?

Standard Biotools Inc share price today is $0.99 as on at the close of the market. Standard Biotools Inc share today touched a day high of $1 and a low of $0.95.

What is the 52 week high and 52 week low for Standard Biotools Inc share?

Standard Biotools Inc share touched a 52 week high of $1.72 on and a 52 week low of $0.92 on . Standard Biotools Inc stock price today i.e. is closed at $0.99,which is 42.44% down from its 52 week high and 7.61% up from its 52 week low.

What is Standard Biotools Inc's market capitalisation today?

Standard Biotools Inc market capitalisation is $0.00T as on .

How to invest in Standard Biotools Inc Stock (LAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Standard Biotools Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Standard Biotools Inc Shares that will get you 1.5152 shares as per Standard Biotools Inc share price of $0.99 per share as on March 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Standard Biotools Inc Stock (LAB) from India?

Indian investors can start investing in Standard Biotools Inc (LAB) shares with as little as ₹93.708 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹937.08 in Standard Biotools Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Standard Biotools Inc share’s latest price of $0.99 as on March 21, 2026 at 1:29 am IST, you will get 10.1010 shares of Standard Biotools Inc. Learn more about fractional shares .